“Low Dose Ganciclovir for Cytomegalovirus Reactivation after Allogeneic HSCT Is a Feasible Option with Same Efficacy and Less Toxicity Than Regular Dose”

Bibliographic Details
Title:	“Low Dose Ganciclovir for Cytomegalovirus Reactivation after Allogeneic HSCT Is a Feasible Option with Same Efficacy and Less Toxicity Than Regular Dose”
Authors:	Azevedo, Roberta ^, Molla, Vinicius Campos ^, Ramos, Jessica Fernandes ^, Ponciano, Danilo Belchior ^, Moraes, Pedro Henrique Arruda De ^, Da Fonseca, Ana Rita ^, Seiwald, Maria Cristina Nunez ^, Serpa, Mariana ^, Ferreira, Aliana Meneses, Szor, Roberta Shcolnik ^, Leonel, Rayana Bomfim ^, Xavier, Erick Menezes ^, Tucunduva, Luciana ^, Rocha, Vanderson ^, Novis, Yana ^, Kallas, Esper ^*, Nucci, Marcio, Arrais-Rodrigues, Celso
Source:	In Blood 5 November 2020 136 Supplement 1:30-31
Database:	ScienceDirect